12.14
Schlusskurs vom Vortag:
$12.20
Offen:
$12.18
24-Stunden-Volumen:
409.97K
Relative Volume:
1.46
Marktkapitalisierung:
$475.65M
Einnahmen:
$771.65M
Nettoeinkommen (Verlust:
$-120.49M
KGV:
-3.8056
EPS:
-3.19
Netto-Cashflow:
$-73.76M
1W Leistung:
+0.25%
1M Leistung:
-6.33%
6M Leistung:
-32.85%
1J Leistung:
-19.66%
Orthofix Medical Inc Stock (OFIX) Company Profile
Firmenname
Orthofix Medical Inc
Sektor
Branche
Telefon
214-937-2000
Adresse
3451 PLANO PARKWAY, LEWISVILLE, TX
Vergleichen Sie OFIX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OFIX
Orthofix Medical Inc
|
12.14 | 474.48M | 771.65M | -120.49M | -73.76M | -3.19 |
![]()
ABT
Abbott Laboratories
|
134.80 | 231.82B | 42.34B | 13.50B | 6.66B | 7.71 |
![]()
BSX
Boston Scientific Corp
|
106.04 | 152.18B | 17.55B | 2.03B | 2.72B | 1.37 |
![]()
SYK
Stryker Corp
|
394.21 | 145.57B | 23.22B | 2.86B | 3.58B | 7.40 |
![]()
MDT
Medtronic Plc
|
86.44 | 107.07B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
78.00 | 43.22B | 5.54B | 4.18B | 623.10M | 7.00 |
Orthofix Medical Inc Stock (OFIX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-22 | Eingeleitet | Canaccord Genuity | Buy |
2024-11-08 | Hochstufung | Stifel | Hold → Buy |
2024-05-08 | Hochstufung | ROTH MKM | Neutral → Buy |
2023-10-20 | Eingeleitet | ROTH MKM | Neutral |
2023-09-12 | Herabstufung | BTIG Research | Buy → Neutral |
2023-09-12 | Herabstufung | Stifel | Buy → Hold |
2023-07-19 | Fortgesetzt | BTIG Research | Buy |
2022-03-04 | Hochstufung | Stifel | Hold → Buy |
2020-10-20 | Eingeleitet | Stifel | Hold |
2019-10-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
2017-06-21 | Eingeleitet | BTIG Research | Buy |
2017-06-14 | Eingeleitet | Ladenburg Thalmann | Buy |
2017-05-23 | Eingeleitet | SunTrust | Buy |
2015-07-10 | Eingeleitet | Sidoti | Buy |
2013-05-09 | Herabstufung | Mizuho | Buy → Neutral |
2013-01-08 | Bestätigt | Mizuho | Buy |
2010-06-21 | Eingeleitet | Boenning & Scattergood | Outperform |
2010-03-09 | Bestätigt | Jefferies & Co | Buy |
2010-02-18 | Hochstufung | Susquehanna Financial | Neutral → Positive |
2010-01-22 | Eingeleitet | Jefferies & Co | Buy |
2009-11-03 | Hochstufung | Wells Fargo | Underperform → Market Perform |
2009-07-31 | Bestätigt | Jefferies & Co | Buy |
2009-07-31 | Hochstufung | Thomas Weisel | Market Weight → Overweight |
2009-05-26 | Bestätigt | Jefferies & Co | Buy |
2009-04-17 | Herabstufung | Wachovia | Mkt Perform → Underperform |
2009-02-19 | Eingeleitet | Canaccord Adams | Buy |
2008-07-07 | Herabstufung | Wachovia | Outperform → Mkt Perform |
Alle ansehen
Orthofix Medical Inc Aktie (OFIX) Neueste Nachrichten
Shareholder Rights Advocates at Levi & Korsinsky Investigate Orthofix Medical Inc. (OFIX) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Wire Cerclage Sternal Closure Systems Market Top Players - openPR.com
Insider Spends US$125k Buying More Shares In Orthofix Medical - simplywall.st
ORTHOFIX MEDICAL 24 HOUR DEADLINE ALERT: FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Deadline in Class Action Lawsuit Against Orthofix Medical, I - ACCESS Newswire
Insider Buying: Alan Bazaar Acquires Shares of Orthofix Medical Inc (OFIX) - GuruFocus
Orthofix Medical Executives Increase Their Holdings - TradingView
Orthofix Medical Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before October 21, 2024 to Discuss Your RightsOFIX - ACCESS Newswire
Bone Grafts and Substitutes Market to Reach $4.4 Billion by 2033, - openPR.com
Lost Money on Orthofix Medical Inc.(OFIX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire
Class Action Filed Against Orthofix Medical Inc. (OFIX)October 21, 2024 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Shareholders that lost money on Orthofix Medical Inc.(OFIX) should contact Levi & Korsinsky about pending Class ActionOFIX - ACCESS Newswire
Orthofix Medical Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights – OFIX - ACCESS Newswire
Shareholders that lost money on Orthofix Medical Inc. (OFIX) should contact Levi & Korsinsky about pending Class ActionOFIX - ACCESS Newswire
Orthofix targets $808M to $816M revenue in 2025 with key product launches - MSN
Lost Money on Orthofix Medical Inc. (OFIX)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire
Bone Regeneration Market Size, Share, Growth | 2025-2034 - Allied Market Research
Stifel maintains Buy on Orthofix stock, reiterates $24 target By Investing.com - Investing.com Australia
Institutional investors may adopt severe steps after Orthofix Medical Inc.'s (NASDAQ:OFIX) latest 15% drop adds to a year losses - simplywall.st
Orthofix Medical Inc. (NASDAQ:OFIX) Q1 2025 Earnings Call Transcript - Insider Monkey
Orthofix Q1 2025 net sales increase 3% to USD 193.6M - Medical Buyer
Orthofix Medical Inc (OFIX) Q1 2025 Earnings Call Highlights: Strong Growth in Orthopedics and ... - Yahoo Finance
Orthofix Medical Inc (OFIX) Q1 2025 Earnings Call Highlights: Strong Growth in Orthopedics and ... By GuruFocus - Investing.com Canada
Orthofix Medical Reports Q1 2025 Financial Growth - TipRanks
Orthofix: Q1 Earnings Snapshot - Midland Daily News
Stifel maintains Buy on Orthofix stock, reiterates $24 target - Investing.com
Orthofix Medical Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:OFIX) - Seeking Alpha
Earnings call transcript: Orthofix Q1 2025 misses EPS forecasts, shares fall - Investing.com
Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
OFIX Exceeds Q1 Revenue Expectations Amid Business Transformatio - GuruFocus
Orthofix (OFIX) Revises FY25 Sales Outlook and Confirms EBITDA G - GuruFocus
Orthofix (OFIX) Revises FY25 Sales Outlook and Confirms EBITDA Guidance | OFIX Stock News - GuruFocus
Orthofix Reports First Quarter 2025 Financial Results - BioSpace
ORTHOFIX MEDICAL Earnings Results: $OFIX Reports Quarterly Earnings - Nasdaq
Orthofix Medical Inc (OFIX) Q1 Earnings: Revenue Surpasses Estimates at $193.6M, EPS Misses with $(1.35) Loss - GuruFocus
OFIX Exceeds Q1 Revenue Expectations Amid Business Transformation | OFIX Stock News - GuruFocus
Orthofix Gains FDA Clearance for New Bone System - TipRanks
Orthofix Q1 2025 slides: revenue grows 6% as EBITDA margins expand - Investing.com Australia
Orthofix Q1 2025 slides: revenue grows 6% as EBITDA margins expand By Investing.com - Investing.com South Africa
Orthofix Medical Inc. SEC 10-Q Report - TradingView
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Orthofix Medical Inc. (OFIX) Shareholders - ACCESS Newswire
Orthofix Medical Inc (OFIX) Q1 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com
Press Release Distribution & PR Platform - ACCESS Newswire
Finanzdaten der Orthofix Medical Inc-Aktie (OFIX)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):